you are here: HomeNewscoronavirus

Centre fixes COVID-19 vaccine price at Rs 250 per dose

The cost break-up is Rs 150 for a dose plus Rs 100 as a service charge which the private facilities can charge from the beneficiaries.

February 27, 2021 / 04:44 PM IST
Representative Image

Representative Image

The Union Government has fixed the price of vaccines at Rs 250 for a dose which would be available at private hospitals for people above 60 years of age and those above 45 years of age with comorbidities, and will be vaccinated starting March 1, sources said.

However, the prices are subjected to change until further notice. The government has decided that the people will be vaccinated free of cost at the government hospitals.

The cost break-up is Rs 150 for a dose plus Rs 100 as a service charge which the private facilities can charge from the beneficiaries.

The decision was taken by National Health Mission and is being forwarded to all the states and union territories, sources informed.

After healthcare and frontline workers, the third phase of vaccination against Covid-19 pandemic is unrolling beginning March to cover 27 crore of people at 10,000 government and over 20,000 private vaccination centres.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
The vaccines will be stored at public health facilities having cold chain points. The private facilities will be able to receive the desired doses from public hospitals in their vicinity.
IANS
first published: Feb 27, 2021 04:44 pm

stay updated

Get Daily News on your Browser
Sections